Drug Interactions Drugs that may increase the risk of hypoglycemia: antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics
A 2022 analysis published in Diabetes, Obesity and Metabolism found that semaglutide treatment was associated with significant improvements in patient-reported energy levels and physical functioning scores, with improvements correlating with both weight loss magnitude and reductions in inflammatory markers (Wilding et al., Diabetes, Obesity and Metabolism, 2022, What GLP-1 Medications Cannot Do for Fatigue This is worth addressing directly, because theres a real risk of patients attributing all their fatigue to weight and expecting GLP-1 medications to fix everything
PMID: 136 WangYLiSLiC
Toyoda M, Kaira K, Ohshima Y, Ishioka NS, Shino M, Sakakura K, et al
10.1016/j.molmet.2019.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar] Nguyen, A
Empire Medical Training: Leading the Way in Obesity Management Education Ready to put this into practice
